This workshop series focuses on selecting optimal treatment strategies for patients with MS. It includes evidence- and case-based discussions on the evolving treatment landscape, selection of initial therapy, assessment of treatment response, and modification of therapy. 

Upon completion, participants should be able to:

• Explain why early and ongoing treatment is important for patients with MS

• Review clinical evidence describing the safety, efficacy, and optimal use of available DMTs in individualized MS treatment regimens

• Describe methods for monitoring disease status and the limitations of those methods

•  Develop strategies for identifying and managing suboptimal response to DMT

• Integrate effective communication strategies in routine practice to educate patients with MS about their disease and its treatment and engage them as active members of their healthcare team

This workshop series for neurologists, nurse practitioners, and physician assistants focuses on optimal treatment strategies for patients with MS through evidence- and case-based discussions on the selection of initial therapy, assessment of treatment response, and modification of therapy.

WORKSHOP AGENDA

  9:30 AM - 10:00 AM     Sign-In

10:00 AM - 10:15 AM    Case Presentation 1: Atypical Neurologic Symptoms in a Young Woman: Diagnosis and Differentiation

10:15 AM - 10:20 AM    The Evolving Treatment Landscape

10:20 AM - 10:40 AM    Case Presentation 2: Selecting Initial Therapy

10:40 AM - 11:10 AM    MS Therapies and Early Intervention

11:10 AM - 11:25 AM    Small Group Discussion: Applying the Evidence to Initial Treatment Planning

11:25 AM - 11:40 AM    Monitoring Treatment Response and Modifying Therapy

11:40 AM - 11:55 AM   Small Group Discussion: A Patient Who Is No Longer Responding Well to Initial Treatment

11:55 AM - 12:00 PM   Conclusions and Final Comments

Note: Order of agenda is subject to change.

There is no fee for this meeting.        

Click here to register.

Physician Assistants: This program has been reviewed and is approved for a maximum of 2.0 hours of AAPA Category I CME credit by the Physician Assistant Review Panel. Physician assistants should claim only those hours actually spent participating in the CME activity. This program was planned in accordance with AAPA's CME Standards for Live Programs and for Commercial Support of Live Programs.

Nurse Practitioners: This program is approved for 2.0 contact hours of continuing education by the American Association of Nurse Practitioners. Program ID 1405246. This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.

Physicians: Med-IQ is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Med-IQ designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Others: Other healthcare professionals who successfully complete the activity will receive a Statement of Participation indicating the maximum credits available.